A Phase I Study in Patients with Solid or Hematologic Malignancies of the Dose Proportionality of Subcutaneous Azacitidine and Its Pharmacokinetics in Patients with Severe Renal Impairment
Year: 2013
Type: article
DOI: 10.1002/phar.1371
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
Funder: Celgene
OpenAlex ID: W2157372635
